Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies.
about
Impact of Human Leukocyte Antigen Loci and Haplotypes on Intestinal Acute Graft-versus-host Disease after Human Leukocyte Antigen-matched Sibling Peripheral Blood Stem Cell TransplantationHigh incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients.Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failureSubsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvest.The Relationship between STR-PCR Chimerism Analysis and Chronic GvHD Following Hematopoietic Stem Cell Transplantation.BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation.Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature.Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients.Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 cases.Chronic GVHD is associated with lower relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors.GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT.
P2860
Q33755576-5B8425F2-54A1-4E26-903E-72938F3E72F4Q33950015-19146282-CEF3-4C25-B06D-0B26F537B59CQ36083484-9E53C77B-0B11-493A-80CA-4C7CBD731945Q37377933-6D9D8385-08FD-45FF-9F8A-63A257F9F8D2Q37682117-91E37928-B84A-4695-AB74-BFFF07E98091Q38922475-A324F68B-C74B-4F96-858C-E75D11F91EB2Q39090537-9DD2B5B6-5B59-4FFF-A02E-7D232720598FQ42211287-47DE4801-E8B8-40E9-8CC7-85B6EF5B01EFQ43965339-83D8B0C5-5489-4AEE-8049-D20B543248D7Q44884259-5E35C5DF-8EF0-46D7-9607-2C1EEB44DD14Q48261069-CBE523D5-C57B-4C59-8C4C-F16929002AA0
P2860
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Donor characteristics affectin ...... for hematologic malignancies.
@ast
Donor characteristics affectin ...... for hematologic malignancies.
@en
type
label
Donor characteristics affectin ...... for hematologic malignancies.
@ast
Donor characteristics affectin ...... for hematologic malignancies.
@en
prefLabel
Donor characteristics affectin ...... for hematologic malignancies.
@ast
Donor characteristics affectin ...... for hematologic malignancies.
@en
P2093
P2860
P1476
Donor characteristics affectin ...... for hematologic malignancies.
@en
P2093
Adrian P Gee
Alison Loren
David I Marks
Fangyu Kan
Jakob R Passweg
John Gibson
Luis M Isola
Mary Eapen
Mary J Laughlin
Mei-Jie Zhang
P2860
P304
P356
10.1016/J.BBMT.2011.07.008
P577
2011-07-20T00:00:00Z